Murphy To Pharma CEOs: What Do You Say To Americans Who Pay High Prices For Prescription Drugs And See You Spend Millions More On Stock Buybacks And Dividends Than R&D?
February 08, 2024
February 08, 2024
WASHINGTON, Feb. 8 -- Sen. Christopher Murphy, D-Connecticut, issued the following news release:
U.S. Senator Chris Murphy (D-Conn.) on Thursday spoke at a U.S. Health, Education, Labor & Pensions Committee hearing on the high cost of prescription drugs in the United States. In his questions to Johnson & Johnson CEO Joaquin Duato and Bristol Myers Squibb CEO Chris Boerner, Murphy pressed the executives on why the prices of lifesaving medications are so high for Americans as . . .
U.S. Senator Chris Murphy (D-Conn.) on Thursday spoke at a U.S. Health, Education, Labor & Pensions Committee hearing on the high cost of prescription drugs in the United States. In his questions to Johnson & Johnson CEO Joaquin Duato and Bristol Myers Squibb CEO Chris Boerner, Murphy pressed the executives on why the prices of lifesaving medications are so high for Americans as . . .